Erythromycin Stearate is a macrolide, acid labile compound derived from Erythromcyin. Erythromycin is a potent macrolide inhibitor of CYP3A4 with anti-inflammatory and prokinetic properties. Macrolides belong to a group of antibiotics that bind to the 50S ribosomal subunit and inhibit protein synthesis. Mouse studies show Erythromycin Stearate increases IL-1 and IL-2 levels.
ERTHROMYCIN STERATE
Structure
Product Description
Details |
|
|---|---|
Chemical Name |
ERTHROMYCIN STERATE |
IUPAC Name |
(2R,3R,4S,5R,8R,9S,10S,11R,12R,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-3,4,12-trihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6-oxacyclotetradecane-1,7-dione; octadecanoic acid |
CAS Number |
643-22-1 |
Molecular Formula |
C55H103NO15 |
Synonyms |
oe7;Wemid;ethril;erypar;Ethryn;eratrex;meberyt;Eryprim;pfizer-e;qidmycin |
Application |
Macrodiles antibacterial |